Compare Stocks

The Invesco BulletShares 2028 High Yield Corporate Bond ETF (BSJS) is an exchange-traded fund that mostly invests in high yield fixed income. The fund tracks a market-value-weighted index of USD-denominated corporate high yield bonds with effective maturities in 2028. BSJS was launched on Sep 16, 2020 and is managed by Invesco.

The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.

Belgravia Capital International Inc, formerly known as IC Potash Corp, is a Canada-based company focused on the provision of value-added services to the international Cannabis industry. The Company's activities include the production of specialized organic fertilizers for Cannabis plants, as well as research and development in the area of agronomics through its wholly owned subsidiary, ICP Organics Corp. Additionally, the Company is engaged in the development of blockchain technology software to support the cultivation and distribution processes, such as seed to sale tracking and quality attestation of intermediate and consumer products. The Company is also developing a royalty-streaming subsidiary.

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs primarily for the United States market. It targets underserved therapeutic areas, such as central nervous system (CNS), including pain, neurology, and psychiatry. The company's products comprise Zohydro ER with BeadTek, an opioid agonist indicated for the management of pain; Silenor, a non-narcotic, non-scheduled, and non-addictive prescription sleep aid for the treatment of insomnia characterized by difficulty with sleep maintenance; and Treximet, a fixed dose combination product indicated for the treatment of acute migraine. Pernix Therapeutics Holdings, Inc. markets and sells its non-core products, including generics through its wholly owned subsidiaries; and markets its non-promoted products through distributors and trade partners. It serves drug wholesalers, specialty pharmacies, retail drug stores, mass merchandisers, and grocery store pharmacies. Pernix Therapeutics Holdings, Inc. was founded in 1996 and is headquartered in Morristown, New Jersey.